TSX News -
Trillium Therapeutics Introduces Industry Postdoctoral Fellowship Program
TORONTO, ONTARIO–(Marketwired – Aug. 31, 2016) – Trillium Therapeutics Inc. (NASDAQ:TRIL)(TSX:TR), a clinical stage immuno-oncology company developing innovative therapies for [...]